Case Study: Leading Pharma Co. Protects Its Scientific Research Data Authenticity And Ownership

Bringing a new healthcare product or treatment to market can mean an investment of many years and millions of dollars for a pharmaceutical company. As a strong part of their commitments to patients and to company stakeholders, many pharmaceutical companies are working to reduce the product development and introduction timeframe by streamlining processes with lab automation technologies, such as Electronic Lab Notebooks (ELNs). Faced with increasing competitive and compliance pressures, pharmaceutical firms also are striving to ensure that their electronic records and intellectual property can stand up to litigation or regulatory challenges.